The integrase inhibitor dolutegravir suppresses the production of a key signalling chemical in fat cells that is also suppressed in obesity, Spanish researchers report in the journal Life Sciences.
The finding that dolutegravir suppresses the production of adiponectin, a chemical secreted by fat tissue that regulates insulin sensitivity, confirms research carried out by a French research group, and provides further evidence that dolutegravir can have direct effects on the human cells that store fat.
Read the full story at Aidsmap.
Source : Aidsmap
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.